Kimberly A Kolonich, MD | |
1850 E Park Ave Ste 201, State College, PA 16803-6706 | |
(844) 278-4600 | |
(814) 231-7098 |
Full Name | Kimberly A Kolonich |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 35 Years |
Location | 1850 E Park Ave Ste 201, State College, Pennsylvania |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467489344 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | MD046362L (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Geisinger-lewistown Hospital | Lewistown, PA | Hospital |
Mount Nittany Medical Center | State college, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mount Nittany Medical Center Health Services Inc | 8426136797 | 196 |
News Archive
Teenagers are known for their angst-ridden ways, but those who remain happy and positive during the tumultuous teenage years report better general health when they are adults, according to a new Northwestern University study.
Use of a fall prevention tool kit, which included a fall risk assessment, patient-specific prevention plan, an educational handout and a poster for over the patient's hospital bed reduced the number of older patients with falls in hospitals, according to a study in the November 3 issue of JAMA, a theme issue on aging.
Results from a new clinical study conducted at Uppsala University suggest that curtailing sleep alters the abundance of bacterial gut species that have previously been linked to compromised human metabolic health.
On Friday, March 13, 2015, as part of its 20th Annual Conference: Advancing the Standard of Cancer Care, the National Comprehensive Cancer Network hosted its second roundtable, Value-Based Decision-Making at the Bedside, which reflected on the tools available to oncology clinicians, such as clinical practice guidelines and pathways, and how the use of these tools has impacted bedside evidence-based decision-making for both physicians and patients, the criteria used to assess shared decision-making, and the relationship between outcomes and cost when determining value.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.
› Verified 3 days ago
Entity Name | Mount Nittany Medical Center Health Services Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1164691499 PECOS PAC ID: 8426136797 Enrollment ID: O20081021000240 |
News Archive
Teenagers are known for their angst-ridden ways, but those who remain happy and positive during the tumultuous teenage years report better general health when they are adults, according to a new Northwestern University study.
Use of a fall prevention tool kit, which included a fall risk assessment, patient-specific prevention plan, an educational handout and a poster for over the patient's hospital bed reduced the number of older patients with falls in hospitals, according to a study in the November 3 issue of JAMA, a theme issue on aging.
Results from a new clinical study conducted at Uppsala University suggest that curtailing sleep alters the abundance of bacterial gut species that have previously been linked to compromised human metabolic health.
On Friday, March 13, 2015, as part of its 20th Annual Conference: Advancing the Standard of Cancer Care, the National Comprehensive Cancer Network hosted its second roundtable, Value-Based Decision-Making at the Bedside, which reflected on the tools available to oncology clinicians, such as clinical practice guidelines and pathways, and how the use of these tools has impacted bedside evidence-based decision-making for both physicians and patients, the criteria used to assess shared decision-making, and the relationship between outcomes and cost when determining value.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Kimberly A Kolonich, MD 96 Kish Rd, Reedsville, PA 17084-8943 Ph: (717) 667-7720 | Kimberly A Kolonich, MD 1850 E Park Ave Ste 201, State College, PA 16803-6706 Ph: (844) 278-4600 |
News Archive
Teenagers are known for their angst-ridden ways, but those who remain happy and positive during the tumultuous teenage years report better general health when they are adults, according to a new Northwestern University study.
Use of a fall prevention tool kit, which included a fall risk assessment, patient-specific prevention plan, an educational handout and a poster for over the patient's hospital bed reduced the number of older patients with falls in hospitals, according to a study in the November 3 issue of JAMA, a theme issue on aging.
Results from a new clinical study conducted at Uppsala University suggest that curtailing sleep alters the abundance of bacterial gut species that have previously been linked to compromised human metabolic health.
On Friday, March 13, 2015, as part of its 20th Annual Conference: Advancing the Standard of Cancer Care, the National Comprehensive Cancer Network hosted its second roundtable, Value-Based Decision-Making at the Bedside, which reflected on the tools available to oncology clinicians, such as clinical practice guidelines and pathways, and how the use of these tools has impacted bedside evidence-based decision-making for both physicians and patients, the criteria used to assess shared decision-making, and the relationship between outcomes and cost when determining value.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated today announced that the United States Food and Drug Administration (FDA) accepted for review a New Drug Application (NDA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for non-hysterectomized women for the treatment of moderate-to-severe vasomotor symptoms (VMS) and vulvar and vaginal atrophy (VVA) associated with menopause, as well as the prevention of postmenopausal osteoporosis.
› Verified 3 days ago
Dr. Ryan R Ridenour, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1800 E Park Ave, State College, PA 16803 Phone: 814-278-4818 Fax: 814-234-6150 | |
Dr. Wasiq Mateen Ahmad, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1850 E Park Ave Ste 207, State College, PA 16803 Phone: 814-235-2480 | |
Franklin James Berkey, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 476 Rolling Ridge Dr, Suite 101, State College, PA 16801 Phone: 814-689-4980 Fax: 814-689-4990 | |
Stephen Pandolph, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1528 Martin St, Suite 210, State College, PA 16803 Phone: 814-234-4811 | |
Gary Franklin Schell, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 140 W North Hills Pl, State College, PA 16803 Phone: 814-238-8880 Fax: 814-765-8499 | |
Stacy Emile, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1800 E Park Ave, State College, PA 16803 Phone: 814-278-4818 | |
Jesse Julian Miller, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1850 E Park Ave Ste 112, State College, PA 16803 Phone: 800-243-1455 Fax: 814-863-7803 |